These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7993954)
41. Platelet 3H-imipramine binding and response to minaprine in patients with major depression. Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597 [TBL] [Abstract][Full Text] [Related]
42. Binding of yohimbine and imipramine to platelets in depressive illness. Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789 [TBL] [Abstract][Full Text] [Related]
44. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior. Kim SW; Dysken MW; Pandey GN; Davis JM Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222 [TBL] [Abstract][Full Text] [Related]
45. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196 [TBL] [Abstract][Full Text] [Related]
46. The effect of citalopram treatment on platelet serotonin function in panic disorders. Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339 [TBL] [Abstract][Full Text] [Related]
48. Platelet [3H]paroxetine binding in panic disorder. Maguire KP; Norman TR; Apostolopoulos M; Judd FK; Burrows GD J Affect Disord; 1995 Feb; 33(2):117-22. PubMed ID: 7759659 [TBL] [Abstract][Full Text] [Related]
49. Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration. Roy A; Everett D; Pickar D; Paul SM Arch Gen Psychiatry; 1987 Apr; 44(4):320-7. PubMed ID: 2436589 [TBL] [Abstract][Full Text] [Related]
50. Decreased platelet 3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly outpatients. Schneider LS; Severson JA; Sloane RB; Fredrickson ER J Affect Disord; 1988; 15(2):195-200. PubMed ID: 2851620 [TBL] [Abstract][Full Text] [Related]
51. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes. Mellerup ET; Plenge P Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152 [TBL] [Abstract][Full Text] [Related]
58. High-affinity 3H-imipramine binding in platelets of children and adolescents with major affective disorders. Rehavi M; Weizman R; Carel C; Apter A; Tyano S Psychiatry Res; 1984 Sep; 13(1):31-9. PubMed ID: 6595683 [TBL] [Abstract][Full Text] [Related]
59. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276 [TBL] [Abstract][Full Text] [Related]
60. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]